Dr. Gayana Shankaramurthy
Nuclear Medicine and Theranostics Expert
Qualification
MBBS – Government Medical College, Mysore, MD (Nuclear Medicine) – PGIMER, Chandigarh, FEBNM (Barcelona, 2022), MICNM (New Delhi, 2022)
Basic Details
7483160232
Email ID:
worldoftheranostics@gmail.com
Experience
12.0 Years Of Experience
License Number
Dr. Gayana Shankaramurthy is an accomplished Nuclear Medicine and Theranostics specialist with extensive clinical, academic, and leadership experience. She currently serves as Director & Head, Nuclear Medicine and Theranostics at KIMS Hospitals, Bengaluru, where she developed the department, including isolation wards for radionuclide therapies. Previously, she was Additional Director & Head, establishing the department and therapy facilities. Over her career, Dr. Shankaramurthy has reported 40,000+ PET/CT scans, 45,000 gamma camera studies, and treated 1000+ patients with theranostic procedures such as I-131 therapy, Lu-177/Ac-225 DOTATATE and PSMA ligand therapy,
TARE, and I-131 MIBG therapy. A PGIMER, Chandigarh graduate, she holds gold and silver medals and has presented research internationally at SNMMI (USA) and EANM (Europe). Her expertise spans oncology, cardiology, musculoskeletal imaging, and non-oncological nuclear medicine. Dr. Shankaramurthy is committed to advancing precision oncology, hybrid molecular imaging, and targeted radionuclide therapies, serving as a speaker, researcher, reviewer, and advisory committee member. She is driven by innovation, safety, empathy, and compassionate care, firmly believing that cancer can be effectively treated when diagnosed and managed appropriately.
Connect with Us
- Gold medals in General Medicine & Pediatrics
- Silver Medal (First Order)- MD (Nuclear Medicine) PGIMER Convocation
- Best Paper & Highlighted Speaker – SNM Annual Meeting, USA (2012),EANM Congress (2012) and EANM Hamburg 2024
- Travel Grants – SNMI & ICMR
- Reviewer – Indian Journal of Nuclear Medicine
- Joint Secretary – Indian College of Nuclear Medicine
- Multiple invited speaker roles at national & international conferences
- Diffuse Neuroendocrine Tumor of the Pancreas Diagnosed by Ga-68 DOTANOC PET CT – Clinical Nuclear Medicine (In press)
- Invasive Lobular Carcinoma With Gastric & Uterine Metastases on F-18 FDG PET CT – Indian Journal of Nuclear Medicine, 2025
- Ga-68 DOTATATE PET/CT in Carotid Body Tumor – Clinical Nuclear Medicine, 2013
- Unilateral Breast Uptake of Tc-99m Pertechnetate – World Journal of Nuclear Medicine, 2012
- Ga-68 DOTATATE in Lung Carcinoid – Lung India, 2012
- F-18 Fluoride PET/CT in Avascular Necrosis – Clinical Nuclear Medicine, 2013
- Hybrid SPECT/CT Sulphur Colloid Scintigraphy – World Journal of Nuclear Medicine, 2013
- F-18 FDG PET/CT in Takayasu Arteritis – Journal of Nuclear Cardiology, 2014
- F-18 Fluoride PET/CT in AVN Pre- and Post-Core Decompression – Indian Journal of Nuclear Medicine, 2016
- Fibroblast Activation Protein Inhibitor PET/CT Review – Clinical Nuclear Medicine, 2021
- Executive Committee Member – Society of Nuclear Medicine India (South Chapter)
- Joint Secretary – Indian College of Nuclear Medicine
- Reviewer – Indian Journal of Nuclear Medicine
- Member – Society of Nuclear Medicine (India)
- Member – European Board of Nuclear Medicine (FEBNM)
- Member – ANMPI & various national and international nuclear medicine societies
Our Specialization
Specialized Services in Nuclear Medicine
Nuclear Medicine Imaging
PET CT/ SPECT CT
Theranostics
Targeted Radionuclide diagnosis and therapy
Nuclear Cardiology
Cardiac scans for assessing myocardial perfusion and viability
Advanced Molecular Imaging
Ga-68 FAPI PET CT, Ga-68 Trivexin PET CT, Ga-68 Exendin PET CT, Ga-68 Pentixafor PET CT, and many more
Our Healthcare Services
Theranostics in Prostate Cancer
I-131 Therapy in Thyroid Cancer
MIBG Therapy
Nuclear Cardiology
Theranostics in NET
TARE (Transarterial Radioembolization)
PET/CT (Oncological & Non-Oncological)
SPECT/CT
Renal Scintigraphy
Imaging for Avascular Necrosis
Media Pictures
